As of 2026-01-05, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (389.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -161496.9%.
The range of the Relative Valuation is (381.51) - (403.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 17.5x | 17.0x |
| Forward P/E multiples | 15.9x - 17.5x | 16.7x |
| Fair Price | (381.51) - (403.68) | (389.13) |
| Upside | -158336.0% - -167531.3% | -161496.9% |
| Date | P/E |